Stéphane Culine

5PUBLICATIONS
65CO-AUTHORS
ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 02, 2026
Phase Ib Trial of Bavdegalutamide (ARV-110) in Combination with Abiraterone for Metastatic Prostate Cancer.

|May 04, 2023
Short-course treatment after complete response to pembrolizumab in metastatic urothelial bladder cancer: a case series.

Henri Plais, Clément Dumont, Hélène Gauthier

|Mar 29, 2023
Refining the Characterization and Outcome of Pathological Complete Responders after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Lessons from the Randomized Phase III VESPER (GETUG-AFU V05) Trial.

Stéphane Culine, Valentin Harter, Clémentine Krucker

|Mar 05, 2022
Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from the KEYNOTE-045 and KEYNOTE-052 Landmark Trials.

Joaquim Bellmunt, Ronald de Wit, Yves Fradet

|Mar 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.

Jörg Beyer, Laurence Collette, Nicolas Sauvé

Pageof 1

Frequent Collaborators

2 joint publications

Cora N Sternberg

2 joint publications

Andrea Necchi

1 joint publications

Jörg Beyer

1 joint publications

Laurence Collette